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1081-117 Inaccuracy of the Rose/WHO and the Edinburgh 
Modification Questionnaires for Detecting Peripheral 
Arterial Disease in Patients With Coronary Artery 
Disease 
Robert S. Dieter, Jon Tomasson, Thor Gudjonsson, Roger Brown, Mark Vitcenda, Jean 
Einerson, Pamela Douglas, Timothy E. Tanke, Ford Ballantyne, III, Jonathan C. 
Maklelski. Patrick E. McBride, University of Wisconsin, Madison, WI 
Background: Synchronous peripheral arterial disease (PAD) and coronary artery disease 
(CAD) is common. The RoseNJHO questionnaire and later the Edinburgh modification of 
this questtonnaire was developed to screen for PAD. Little data are available on the sen- 
sitivity of these questionnaires in hospitalized patients with CAD. The aim of our study 
was to determine the accuracy of these questionnaires as screenmg methods for PAD in 
hospitalized patients with CAD. 
Methods: Medically stable patients with proven CAD were invited to participate poor to 
hospital discharge. Data regarding cardiovascular risk factors, history of prewous PAD 
and PAD evaluation/treatment, medication use and, physical examination were collected. 
The patients answered both the WHO/Rose and Edinburgh modification claudication 
questionnaires and had an ankle-brachial index (ABI) measured. An ABI less than or 
equal to 0.9 was considered to be indicative of significant PAD. Patients who had under- 
gone previous lower extremity revascularization for PAD and had a corrected A81 greater 
than 0.9 were not considered for this analysis to have significant PAD. 
Results: 95 patients (66 men) were recruited. By measuring the ABI, thirty five patients 
(25 men) were found to have significant PAD; the mean ABI was 0.70 (range: 0.0-0.90). 
An additional three patients who had an ABI corrected by lower extremity revasculariza- 
tion were excluded from the analysis. The RoseNVHO questionnaire had a sensitivity, 
speoificity. and overall accuracy (95% C.I.) of: 14.3 % (2 7-25.9%), 96.7% (92.1.lOO%), 
66.3% (56-B-75.8%) respectively. The Edinburgh modification of the RoseNVHO ques- 
tionnaire had a sensitivity, specificity. and overall accuracy (95% C.I.) of: 28.6% (13.6- 
43.5%), 90.0% (82.4.97.6%), 67.4% (57.9.76.8%) respectively. 
Conclusions: Despite the high incidence of synchronous PAD and CAD in hospitalized 
patients with CAD, traditional claudication questionnaires are insensitive to PAD detec- 
tion. These results demonstrate that the ankle-brachial Index should be a standard part 
of the examination of patients with CAD and emphawe that a better screemng question- 
naire Is needed to detect PAD in patients with CAD. 
1081-118 Quality of Care for Patients With Peripheral Vascular 
Disease During Acute Coronary Syndromes: insights 
From the Global Registry of Acute Coronary Events 
(GRACE) 
James 8. Froehlich, Debabrata Mukherjee, Alvaro Avezum. Andrzej Budaj, Eva M. Kline- 
Rogers, Jose Lopez-Sendon, Jeanna Johnson, Kim A. Eagle, Rajendra H. Mehta, 
University of Massachusetts Medica! School. Worcester, MA. University of Michtgan 
MedIcal School, Ann Arbor, Ml 
Background Peripheral vascular disease (PVD) is a significant risk factor for cardlovas- 
cular events. The impact of PVD on care during acute coronary syndromes (ACS) is 
unknown. 
Methods To study the effect of PVD on the care of patients with ACS, we evaluated 
17.866 such patients enrolled in GRACE. 
Results History of PVD was present in 1880 (10.6 %) ACS patients. Compared to 
patients without PVD, they had significantly more comorbidities and inhospital cardlovas- 
cular events. In spite of this higher nsk profile, patients with PVD were less kkely to 
undergo revascularization (OR 0.60, 95%CI 0.73-0.90, pcO.0001) or catheterization (OR 
0.84, 95%CI 0.76-0.92). Patients with PVD were also less likely to recewe rep&I&n 
therapy (when indicated) (OR 0.60; 95%CI 0.46-0.77, p-=0.0001), aspirin in hospital (OR 
0.58, 95%CI 0.46-0.74, p<O.OOOl) or beta-blocker at discharge (OR 0.70, 95%CI 0.58. 
0.83, pcO.0001) (Table). There was a non-significant trend toward lower use of aspirin 
and Ilpid-lowering agents at discharge. 
Treatmenl PVD Patients No PVD patients P value 
Reperfwon therapy’ 150/261 (57.5%) 2621/3777 (69.4%) <o.ooo 
1 
Aspirin in-hospital* 1198/1279 12550/13042 <o.ooo 
(93.7%) (96.2%) 1 
Aspirin at discharge’ 800/893 (89.6%) 748118207 (91.2%) 0.1199 
Beta-blocker at discharge’ 458/645 (71.0%) 5277/6774 (77.9%) co.ooo 
1 
ACE-inhibltor at discharge’ 217/291 (74.6%) 1609/2085 (77.2%) 0.3246 
Lipid-Lowering agent at 136/213 (63.9%) 146312090 (70.0%) 0.0634 
discharge’ 
Smokmg cessation counseling 136/211 (64.5%) 1373/2056 (66.8%) 0.4954 
*Among patients with indications, and without contramckcahons. 
Conclusions The quality of care of patients wth PVD who present with acute coronary 
syndromes is suboptimal in spite of their higher risk profile and poorer outcomes. Quality 
improvement strategies, such as those employed by the AHA-sponsored Get with the 
Guidelines and the ACC-sponsored Guidelines Applied in Practice programs, should tar- 
get this high-risk cohort of PVD patients wth ACS to improve their long-term outcomes. 
1081-119 Chronotropic Response to Exercise in Patients With 
Peripheral Arterial Disease Without Classical 
Symptoms of Intermittent Claudication 
Susan D. TiukinhoY_. Ty Gluckman, Shay Unterreiner, Philip Greenland, Mary M. 
McDermott, Northwestern Universjty, Chicago, IL 
There is little information on clinical abnormalities in patients with peripheral arterial dis- 
ease (PAD) without classical symptoms of intermittent claudication (IC). Although these 
p&tents have functional limitations similar to PAD patients with IC, they are often not tar- 
geted for aggressive preventwe care We aimed to identify parameters that can be used 
to assess cardiovascular risk in these patients. Chronotropic incompetence is an inde- 
pendent predictor of death and incident coronary events in other pattent groups. We 
hypothesized that patients with PAD without IC are a high-risk group, and will have 
abnormal chronotropic response to exercise. Methods: Patients with ankle-brachial index 
(ABl)c0.9 wlthout classical symptoms of IC were recruited for the study. Patients with 
significant limitations to exercise were excluded. A symptom-limited walkmg treadmill test 
was performed. Chronotropic incompetence ‘was assessed using the chronotropic index 
(Cl) defined as (HRpeak-HRbaseline)/(220-age-HRbaseline), and the heart rate recovery 
(HRR) defined as the dlfference between peak HR and HR at 1 min into recovery. Vali- 
dated functional measures such as the 6.min walk distance, 4-mile velocity, and sum- 
mary performance score were also assessed. Results: 35 consecutive patients were 
included. Mean age was 70 f 9 years (54% male). Mean exercise time was 7 * 4 min- 
utes, (6 METS). 89% failed to reach target HR. Mean Cl was 0.52 * 0.19, With only 3 
patients (8%) having a normal index of z-0.8. Mean HRR was 14 * 9 bpm. with 48% hav- 
ing an abnormal HRR of 512 bpm. HRR and Cl did not correlate with PAD severity nor 
any of the measures of functional disability after controlling for age, sex, treadmill time. 
beta-blocker use, and presence of diabetes. Conclusion: In these patients with PAD with- 
out classical symptoms of IC, we have demonstrated abnormal exercise parameters con- 
slsient with chronotropic incompetence. Cl and HRR are wnple exercise parameters lhat 
predtct increased risk. These measures are independent of markers of functional disabil- 
ity and PAD seventy, and can perhaps be used to identify high-risk patients among this 
cohort that should be targeted for aggressive risk factor modification. 
1081-152 Lipid-Lowering and Secondary Prevention of 
Cardiovascular Disease in Vascular Surgical In-Patients 
James B. Froehlich, Maria Cote, Michael J. Singh. Peter R. Nelson, Michael J. Rohrer, 
Bruce S. Cutler, Universitv of Massachusetts Medical School, Worcester. MA, UMass 
Memorial Medical Center, Worcester, MA 
Background: HMG-CoA reductase inhibitors (slatins). are effectwe secondary preven- 
tion for cardiovascular disease. Few studies have examined the adherence with, and 
predictors of, statin use in patients referred for surgical care of peripheral artery disease 
(PAD). Methods: We prospectively evaluated 355 consecutive PAD patients admitted 
for vascular surgical procedures. We documented history, current medications, and risk 
factor status. We surveyed a subset of 108 consecutive patients regardmg risk factors. 
Univariate associations with stat10 use were tested by chisquare, and a multivariate 
regression analysis evaluated independence of associations. 
Results: Only 53% of subjects were taking statins, of whom only 55% were at LDL goal. 
Only 41% of all patients were at LDL goal. History of coronary artery disease (CAD) pre- 
dicted statin use:. 
Predictor Statin Use With 
Hx CABG 64% 
Hx Ml 73% 
Hx CAD 63% 
Hx PAD only 40% 
Beta-blocker use 62% 
ACE-I “se 63% 
Am-platelet use 61% 
Satin Use Without 
49% 
46% 
37% 
59% 
43% 
47% 
39% 
P 
0.02 
<O.OOl 
<O.cOl 
0 001 
<O.OOl 
0 003 
<O.OOl 
A history PAD wthout CAD was associated with & statin usage (40% vs. 59%, 
0=0.0011. Onlv 30% of subiects had received dietarv counselina, and only 27% knew , I1 
their LDL level. On regression modeling, only a history of CAD, and the use of antiplatelet 
agents, and ACE-lnhjbitors predicted statin use. Conclusions: Statin use and attain- 
ment of LDL treatment goals were disappointmg even in patients with severe PAD. Previ- 
ous history of CAD, though not PAD, was associated v&h increased statin use. These 
data suggest that patients with PAD are not receiving adequate secondary prevention, 
and their treatment is inferior to that received by patients with CAD. 
